| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $751.1M | — | +130.4% |
| Cost of Revenue | $525.5M | — | +121.4% |
| Gross Profit | $225.5M | — | +154.3% |
| R&D Expense | $56.8M | — | +40.0% |
| SG&A Expense | $58.1M | — | +29.3% |
| Operating Income | $72.2M | — | +478.6% |
| Interest Expense | $4.2M | — | -59.6% |
| Pre-tax Income | $74.1M | — | +422.6% |
| Income Tax | $445K | — | +3.2% |
| Net Income | $73.7M | — | +414.7% |
| EPS (Basic) | $0.25 | — | +350.0% |
| EPS (Diluted) | $0.23 | — | +330.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.49B | +1.5% | +213.5% |
| Accounts Receivable | $359.4M | -3.3% | +7.6% |
| Inventory | $732.5M | +13.9% | +19.6% |
| Current Assets | $3.95B | +6.0% | +96.9% |
| Total Assets | $4.66B | +6.1% | +78.9% |
| Current Liabilities | $786.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $73.6M | — | +166.5% |
| Capital Expenditures | $26.2M | — | +83.6% |
| Investing Cash Flow | -$45.9M | — | -223.1% |
| Financing Cash Flow | $7.1M | — | +37.6% |
| Free Cash Flow | $47.4M | — | +138.0% |
| +34.6% |
| Long-term Debt | $2.60B | -0.6% | +130.2% |
| Total Liabilities | $3.72B | +3.1% | +85.2% |
| Stockholders' Equity | $921.5M | +19.9% | +59.3% |